Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors
==========================================================================================================================================================================================================

* Aung Naing
* Joseph P Eder
* Sarina A Piha-Paul
* Claude Gimmi
* Elizabeth Hussey
* Sen Zhang
* Vera Hildebrand
* Vinayak Hosagrahara
* Christina Habermehl
* Jacques Moisan
* Kyriakos P Papadopoulos